Dominik Höchli
Director/Board Member at MOLECULAR PARTNERS AG
Profile
Dominik Höchli is currently the Chief Executive Officer at Catapult Therapeutics BV and an Independent Director at Molecular Partners AG.
He previously worked as the Vice President & Head-Global Medical Affairs at AbbVie AG.
He holds a doctorate degree from the University of Bern.
Dominik Höchli active positions
Companies | Position | Start |
---|---|---|
MOLECULAR PARTNERS AG | Director/Board Member | 21/04/2021 |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Chief Executive Officer | 01/01/2021 |
Former positions of Dominik Höchli
Companies | Position | End |
---|---|---|
AbbVie AG | Corporate Officer/Principal | - |
Training of Dominik Höchli
University of Bern | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
Private companies | 2 |
---|---|
AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
- Stock Market
- Insiders
- Dominik Höchli